Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Deepak Sundriyal
Observed name:
D. Sundriyal
Institutions:
All India Institute of Medical Sciences Rishikesh,
All India Institute of Medical Sciences
Observed institutions:
All India Institute of Medical Sciences Rishikesh,
All India Institute of Medical Sciences
ORCID:
0000-0002-6378-7694
Observed ORCID:
0000-0002-6378-7694
OpenAlex ID:
A5014032109
56P Clinico-pathological profile of adolescent and young adult colorectal cancer patients: Multicentre collaborative registry data from India
2022
·
S.S. Panda
, A. Sehrawat
, et al.
·
Annals of Oncology
·
2
Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India
2026
·
Susheel Kumar Yeshala
, Soumya Surath Panda
, et al.
·
Journal of Ovarian Research
·
1
PDF
Refining early detection of hepatocellular carcinoma: The promise of the GALAD score
2026
·
Harsha S P
, Amit Sehrawat
, et al.
·
World Journal of Gastroenterology
PDF
Epidemiology, Treatment Patterns, and Survival Outcomes in Patients With Uterine Cancer in a Real-World Setting in India
2026
·
Shalini Bose
, Kavita Khoiwal
, et al.
·
Indian Journal of Surgical Oncology
856P Translation and validation of the ‘Strength, ambulation, rising from a chair, stair climbing and history of falling’ (SARC-F) questionnaire into Hindi language among Indian cancer patients: A cross-sectional study
2025
·
A. Sehrawat
, A. Rana
, et al.
·
Annals of Oncology
127P Study of the profile of HER2-positive metastatic breast cancer patients receiving T-DM1 biosimilar, in a real-world setting
2025
·
A. Mahajan
, S.S. Panda
, et al.
·
Annals of Oncology
593TiP The efficacy and safety of mirtazapine vs olanzapine in preventing chemotherapy induced nausea and vomiting in combination with the triplet regimen in patients receiving highly emetogenic chemotherapy: An open label, prospective, randomized control study
2024
·
A. Mruthyunjaya Swamy
, A. Sehrawat
, et al.
·
Annals of Oncology
448P Prevalence of thyroid dysfunction, diabetes, and impact of palliative chemotherapy in advanced metastatic cancer patients: Prospective data from LMIC
2022
·
A. Sehrawat
, G. Karna
, et al.
·
Annals of Oncology
294P Cross-sectional analysis on cancer-related distress, belief in alternative medicine among cancer patients and attendants visiting a tertiary care center in Northern India
2022
·
A. Sehrawat
, S. Malik
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
9
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type